Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Feb 14, 2019
Document Date
Dec 31, 2018
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
NOVARTIS AG